Determination of naftidrofuryl in human plasma by high-performance liquid chromatography with fluorescence detection. - Suppr | 超能文献

Determination of naftidrofuryl in human plasma by high-performance liquid chromatography with fluorescence detection.

作者信息

Walmsley L M, Wilkinson P A, Brodie R R, Chasseaud L F

出版信息

J Chromatogr. 1985 Mar 22;338(2):433-7. doi: 10.1016/0378-4347(85)80117-1.

DOI:10.1016/0378-4347(85)80117-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Determination of naftidrofuryl in human plasma by high-performance liquid chromatography with fluorescence detection.

J Chromatogr. 1985 Mar 22;338(2):433-7. doi: 10.1016/0378-4347(85)80117-1.

2

Determination of naftidrofuryl in the plasma of humans by high-performance liquid chromatography.

J Chromatogr. 1979 Dec 1;164(4):534-40. doi: 10.1016/s0378-4347(00)81559-5.

3

Plasma concentrations and relative bioavailability of naftidrofuryl from different salt forms.不同盐形式萘呋胺酯的血浆浓度及相对生物利用度。

Biopharm Drug Dispos. 1986 Jul-Aug;7(4):327-34. doi: 10.1002/bdd.2510070403.

4

[Determination of naphthidrofuryl and naphthidrofurylic acid in human plasma using RP-HPLC and fluorimetric detection].[采用反相高效液相色谱法和荧光检测法测定人血浆中的萘呋胺酯及萘呋胺酸]

Cesk Farm. 1990 Nov;39(9):394-9.

5

A validated HPLC method for the simultaneous determination of naftidrofuryl oxalate and its degradation product (metabolite), naftidrofuryl acid: applications to pharmaceutical tablets and biological samples.一种用于同时测定萘呋胺草酸酯及其降解产物（代谢物）萘呋酸的 HPLC 验证方法：在药物片剂和生物样品中的应用。

Drug Test Anal. 2013 Jun;5(6):500-8. doi: 10.1002/dta.421. Epub 2012 Feb 28.

6

[Pharmacokinetics of naftidrofuryl in multimorbidity in geriatric patients].老年多病患者中萘呋胺酯的药代动力学

Z Gerontol. 1984 Sep-Oct;17(5):246-50.

7

Determination of manassantin B in rat plasma using a high performance liquid chromatography with fluorescence detection and its quantitative application to pharmacokinetic study.采用高效液相色谱-荧光检测法测定大鼠血浆中马纳桑亭B及其在药代动力学研究中的定量应用。

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 1;1011:121-7. doi: 10.1016/j.jchromb.2015.12.058. Epub 2016 Jan 2.

8

Platelet aggregation after naftidrofuryl application in vitro and ex vivo.萘呋胺酯在体外和体内应用后的血小板聚集情况。

Int J Clin Pharmacol Ther. 1995 Feb;33(2):81-4.

9

Metabolism of nafronyl in man.萘呋胺酯在人体内的代谢

Eur J Drug Metab Pharmacokinet. 1989 Apr-Jun;14(2):133-8. doi: 10.1007/BF03190853.

10

Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.奈呋胺酯治疗慢性动脉疾病。一项对照多中心研究的结果。

Angiology. 1984 Nov;35(11):701-8. doi: 10.1177/000331978403501103.

引用本文的文献

1

Spectrophotometric, spectrofluorimetric and voltammetric analyses of naftidrofuryl oxalate in its tablets.

Int J Biomed Sci. 2009 Sep;5(3):283-92.

2

Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents.药物制剂对纯化的猪和人肝脏视黄酯水解酶的抑制作用。

Lipids. 2001 May;36(5):543-8. doi: 10.1007/s11745-001-0755-z.

3

Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.口服奈呋胺酯。其药理学及治疗外周闭塞性动脉疾病的应用综述。

Drugs Aging. 1996 Apr;8(4):299-322. doi: 10.2165/00002512-199608040-00005.